Cargando...
Pharmacogenomic Biomarkers in US FDA-Approved Drug Labels (2000–2020)
Pharmacogenomics (PGx) is a key subset of precision medicine that relates genomic variation to individual response to pharmacotherapy. We assessed longitudinal trends in US FDA approval of new drugs labeled with PGx information. Drug labels containing PGx information were obtained from Drugs@FDA and...
Gardado en:
| Publicado en: | J Pers Med |
|---|---|
| Main Authors: | , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado: |
MDPI
2021
|
| Assuntos: | |
| Acceso en liña: | https://ncbi.nlm.nih.gov/pmc/articles/PMC8000585/ https://ncbi.nlm.nih.gov/pubmed/33806453 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/jpm11030179 |
| Tags: |
Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!
|